Radiant Research Elects Pamela M. Spaniac as President of the Company
Pam Spaniac joined Radiant Research in 1998 as the Chief Financial Officer and became the Chief Operating Officer in 2002. Her professional background includes more than 19 years of experience in both private and public sector healthcare companies. Prior to her work with Radiant, she served as Executive Vice President and Chief Financial Officer of Res-Care (Nasdaq:RSCR), a large publicly traded healthcare company. Before her work with Res-Care, she was Vice President and Controller of Coram Healthcare Corporation and Director of Finance and Controller of the University of Colorado Hospital Authority. Ms. Spaniac began her career at Ernst & Young. She is a certified public accountant in the state of California and received her BA from Scripps College.
“Mike has been a tremendous mentor over the past nine years and I am honored to be offered the role of President”
"Pam is very well prepared to take on the additional responsibilities of the office of President. She has been a great operational and strategic partner for me as we built an organization from a concept to an enterprise approaching $100 million in revenue with 1,000 dedicated research professionals over the last nine years.
"Mike has been a tremendous mentor over the past nine years and I am honored to be offered the role of President," said Spaniac. "I am excited about the direction we are heading as a company. With our extremely talented team and our renewed focus on late phase clinical research and development services, we continue to differentiate ourselves in the market as the premier comprehensive clinical research and development company."
About Radiant Research:
Based near Seattle, Washington, Radiant Research (radiantresearch.com) is a comprehensive clinical research and development company serving the biopharmaceutical and medical device industry. Radiant is comprised of more than 30 wholly-owned premier clinical research centers nationwide, employing over 500 clinical research professionals exclusively focused on providing professional, high quality study conduct and drug development services. In the past four years, Radiant has conducted more than 8,000 clinical trials across 18 therapeutic specialties.